Beilschmiedia acuta
Beilschmiedia acuta · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Beilschmiedia acuta is a notable botanical species that has garnered interest due to its specific chemical profile. Research has identified the presence of alpha-Hederin within the plant's biological makeup. This particular compound is often studied for its potential physiological effects and medicinal properties. Scientists frequently utilize bark extract as a primary preparation for investigating the plant's bioactive components. Understanding these chemical constituents provides valuable insight into the therapeutic possibilities of this species.
- Synonyms
- Tylostemon Acutifolius
- Common names
- Not available
- Family
- Lauraceae
- Distribution
- Asia-Temperate
- Plant Parts
- Not available
Classification
Synonyms
Beilschmiedia acuta is a botanical species that is often identified by various nomenclature in scientific literature. Within taxonomic records, this plant is also recognized by the synonym Tylostemon acutifolius. Such naming variations frequently occur as researchers refine the classification and history of specific flora. Understanding these overlapping designations is essential for accurate identification in the field. Consequently, recognizing both names ensures that researchers can track the plant's presence across different studies.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Beilschmiedia acuta belongs to the vast kingdom Plantae, representing a diverse group of multicellular organisms. Within this kingdom, the species is classified under the class Equisetopsida. It falls under the specific order Laurales, which helps scientists understand its evolutionary lineage. As a member of the family Lauraceae, it shares many characteristics with other aromatic plants. Finally, this species is defined by its placement within the genus Beilschmiedia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Laurales |
| Family | Lauraceae |
| Genus | Beilschmiedia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Beilschmiedia acuta is a notable plant species primarily found within the diverse ecosystems of Africa. Its presence is most significant across West-Central Tropical Africa, where it plays a role in the local environment. Within this broad geographic range, the species can be specifically located in the lush landscapes of Cameroon. This distribution pattern highlights the plant's reliance on the unique tropical climates found in these specific regions. Understanding its habitat helps researchers better grasp the ecological connections within these African forests.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Beilschmiedia acuta is a tree that maintains a sturdy, self-supporting growth form. This structural stability allows the species to thrive as a prominent feature within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Beilschmiedia acuta is a medicinal plant utilized in Cameroonian traditional medicine for the treatment of various cancer types. Recent investigations into its methanolic extracts have revealed a significant ability to inhibit the proliferation of human cancer cell lines. Specifically, the bark extract of this plant demonstrated high cytotoxicity, even against several multidrug-resistant phenotypes. While the study highlights alpha-hederin as a key constituent of Polyscias fulva, it similarly explores the therapeutic potential of Beilschmiedia acuta extracts. Ultimately, these findings suggest that Beilschmiedia acuta may serve as a valuable resource for developing new drugs to combat drug-resistant cancer cells.
Conditions
Preparations
Beilschmiedia acuta is prepared as a bark extract to be utilized in medicinal research. This specific botanical preparation was tested for its ability to inhibit the proliferation of various human cancer cell lines. During the investigation, the bark extract demonstrated significant cytotoxicity, particularly against CCRF-CEM cells. It also showed potent activity against multiple drug-resistant models, including P-glycoprotein-overexpressing cells. Consequently, this bark-derived extract is considered a valuable candidate for the development of new drugs to combat resistant cancers.